- Report
- March 2025
- 181 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- January 2025
- 157 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- January 2025
- 147 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- January 2025
- 153 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- December 2023
- 504 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- December 2023
- 185 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2023
- 179 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 98 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2024
- 103 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Solubility Enhancement Excipient market is a subset of the Pharmaceutical Intermediates market. It is composed of excipients, which are inactive ingredients used to improve the solubility of active pharmaceutical ingredients (APIs). These excipients are used to increase the bioavailability of APIs, allowing them to be absorbed more quickly and efficiently by the body. Excipients also help to stabilize APIs, preventing them from degrading or reacting with other substances.
The Solubility Enhancement Excipient market is driven by the increasing demand for APIs in the pharmaceutical industry. As the demand for APIs increases, so does the need for excipients to improve their solubility and bioavailability. This has led to an increase in the number of companies offering solubility enhancement excipients. Some of the major players in this market include BASF, Evonik, Roquette, Ashland, and Merck KGaA. Show Less Read more